Additionally, in an orthotopic lung cancer model, established by injecting KRASG12D;p53-/- luciferase-expressing cells into the tail vein, J10 also exhibited a superior tumor suppression effect compared to RK-33 under the same treatment regimen (Fig. 8H–L). The gene discussed is TP53; the disease is lung carcinoma.